Week of May 19 - 25, 2019


Erdafitinib (Balversa™)

Erdafitinib is a tyrosine kinase inhibitor, a targeted therapy indicated for the treatment of some locally advanced or metastatic urothelial cancers.

Trastuzumab-dttb (Ontruzant®)

Trastuzumab-dttb (Ontruzant®) is a biosimilar monoclonal antibody used in the treatment of some types of breast and gastric cancer.

Proton Therapy for Gynecologic Tumors

In this webinar, Dr. Neil Taunk, MD, MS, Assistant Professor and Chief of Gynecologic Radiation Oncology at Penn Medicine, provides an overview of proton radiation therapy for gynecologic cancers.

Blood Products and Transfusions

This section contains articles that explain the different types of blood products, and how and why they are transfused. 

Trastuzumab-pkrb (Herzuma®)

Trastuzumab-pkrb (Herzuma®) is monoclonal antibody biosimilar used in the treatment of some types of breast cancer. 

Iron Deficiency Anemia

This article provides an overview of iron deficiency anemia-its symptoms, risk factors, diagnosis and treatment.

Small Meals and Snacks

This article provides tips for eating small meals and snacks throughout the day during cancer treatment which can help manage treatment and disease related symptoms.

Larotrectinib (Vitrakvi®)

Larotrectinib (Vitrakvi®) is a kinase inhibitor used in the treatment of certain adult and pediatric solid tumors with certain neurotrophic receptor kinase (NTRK) genes.

Rituximab-abbs (Truxima®)

Rituximab-abbs (Truxima®) is a biosimilar, monoclonal antibody used in the treatment of non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL).

Protein Packed Purees

Lauren Clanet, RD, presents a video showing you how to make two different protein packed purees. She also includes the recipes. 

Glasdegib (Daurismo™)

Glasdegib (Daurismo™) is a hedgehog pathway inhibitor used in the treatment of AML in patients 75 years or older in combination with low dose cytarabine.

Gilteritinib (Xospata®)

Gilteritinib (Xospata®) is a kinase inhibitor used in the treatment of acute leukemia with a mutation in the FTL3 gene.

Lorlatinib (Lorbrena®)

Lorlatinib (Lorbrena®) is a tyrosine kinase inhibitor (TKI) used in the treatment of progressive, metastatic non small cell lung cancer.

Talazoparib (Talzenna™)

Talazoparib (Talzenna™) is a PARP inhibitor used in the treatment of some types of breast cancer. 

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
R
S
T
U
V
X
Y
Z
#
 
A
B
C
E
F
G
H
K
L
M
N
O
P
R
S
T
U
V
 
 
Manténgase informado con las última información de OncoLink!   Suscribirse a los boletines electronico de OncoLink
Ver nuestros archivos de boletines